Dogwood Therapeutics News

Dogwood Therapeutics | 8-K: Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

Nov 7 20:18

Dogwood Therapeutics | 8-K: Current report

Oct 30 21:27

Virios Therapeutics | DEFA14A: Others

Oct 7 20:08

Virios Therapeutics | 8-K: Current report

Oct 7 20:03

Virios Therapeutics | 8-K: Virios Therapeutics Announces Second Quarter 2024 Financial Results

Aug 8 21:34

Virios Therapeutics | 8-K: Current report

Jun 20 21:17

Virios Therapeutics | 8-K: Current report

Jun 12 21:16

Virios Therapeutics | 8-K: Current report

May 20 21:30

Virios Therapeutics | 8-K: Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 9 20:02

Virios Therapeutics | 8-K: Current report

May 8 05:31

Virios Therapeutics | DEF 14A: Definitive information statements

Apr 26 04:36

Virios Therapeutics | 8-K: Current report

Mar 7 05:37

Virios Therapeutics | 8-K: Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 29 22:28

Virios Therapeutics | DEFA14A: Others

Feb 28 05:27

Virios Therapeutics | 8-K: Current report

Feb 28 05:23

Virios Therapeutics | DEF 14A: Definitive information statements

Feb 3 05:36

Virios Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Jan 22 13:00

Virios Therapeutics | 8-K: Current report

Jan 3 13:00

Virios Therapeutics | 8-K: Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 13, 2023 20:20

Virios Therapeutics | 8-K: Current report

Nov 7, 2023 20:29